Clinical Trial Update: Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State [Phase 1]

View source ↗

Summary

A Phase 1 clamp study is being conducted to estimate the relative potency of GZR33 versus Insulin Degludec at steady state in Type 1 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GZR33
• insulin degludec (insulin degludec)

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Type 1 Diabetes Mellitis | Phase 1 | Status: RECRUITING